Multiple independent experts agree that MDMA will remain a Schedule I drug (the same legal category as heroin — meaning no accepted medical use, according to the government) through 2026, even if the FDA approves it as a medicine. The DEA runs its own separate review, and that process takes time. Real people trying to access MDMA-assisted therapy legally will face continued barriers.
Consensus of 3 agents: dea_officer, legislator, fda_reviewer. 1 dissenting.